Abstract
This is a response to Jickling and Sharp’s paper discussing the near-complete failure of clinical trials for stroke interventions. While they propose a paradigm shift in the way preclinical research is conducted, I propose that it is clinical trial design that needs an overhaul. Clinical trials could be designed to reduce variance, prevent data entry errors, and encompass less ambitious enrollment criteria limited to fewer centers which have demonstrated expertise in the treatment of stroke (and TBI). Statistical fundamentalism is another soluble problem: clinical trial designs tend to address what is medically significant as opposed to what is primarily statistically significant. Adaptive Design is an alternative to current protocols that needs urgent consideration if we are to get through the Valley of Death between bench and bedside. Maybe it is time to change the clinical trial paradigm to adopt the precise modeling used in good laboratory research rather than asking scientists to give up well-established procedures for producing reliable and reproducible results.
References
Dragalin V (2011) An introduction to adaptive designs and adaptation in CNS trials. Eur Neuropsychopharmacol 21(2):153–158
Jickling GV, Sharp FR (2014) Improving the translation of animal ischemic stroke studies to humans. Published online Feb. 15, 2014; doi:10.1007/s11011-014-9499-2
Kruschke JK (2010) Bayesian data analysis. WIREs Cogn Sci 1:658–676. doi:10.1002/wcs.72
Motulsky HJ (1995) Intuitive biostatistics. Oxford University Press, New York
Tate RL, Godbee K, Sigmundsdottir LA (2013) A systematic review of assessment tools for adults used in traumatic brain injury research and their relationship to the ICF. NeuroRehabilitation 32(4):729–750. doi:10.3233/NRE-130898
van der Graaf R, Roes KC, van Delden JJ (2012) Adaptive trials in clinical research: scientific and ethical issues to consider. JAMA 307(22):2379–2380
World Health Organization International (2003). ICF Checklist for Classification of functioning, disability and health. www.who.int/classifications/icf/training. Accessed August 8, 2014
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stein, D.G. On improving human clinical trials to the level of animal ischemic stroke studies. Metab Brain Dis 30, 469–471 (2015). https://doi.org/10.1007/s11011-014-9613-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9613-5